Thomas Pharm Flashcards
5-FU
Given IV
Must be activated to FdUMP -> inhibits thymidylate synthase
Other actions: inhibition of RNA processing and incorporation into DNA
Combos: + Leucovorin -> enhanced TS inhibition; + Methotrexate -> enhanced 5-FU anabolism and RNA incorporation
Capecitabine
Oral version of 5-FU
Basic principles of oral agents
1) Polar sugar group provides water solubility
2) Lipophilic side group allows the drug to pass through the membranes of the gut and be absorbed orally
3) MUST BE ACID STABLE
Irinotecan
Inhibits topo I
Must be activated to SN38
Used in combo with leucovorin and 5-FU (FOLFIre)
T: diarrhea
Oxaliplatin
Synergistic with 5-FU FOLFOX (leucovorin+5-FU+oxaliplatin)
Binds DNA at promoter region of TS to overcome 5-FU resistance
Intercalates DNA
Erlotinib
Orally active epidermal growth factor receptor (EGFR)-tyrosine kinase reversible inhibitor which blocks EGFR phosphorylation and subsequent signal transduction pathways involved in proliferation, metastasis, angiogenesis, and apoptosis inhibition
Only work in pts that have activating mutation in EGFR gene
Tx: colon cancer
T: diarrhea, rash
Cetuximab
Chimeric monoclonal Ab that binds to the EGFR and inhibits proliferation, angiogenesis, metastasis, and promotes apoptosis
T: Ab-dependent cellular toxicity rxn, transfusion rxns
Panitumumab
Humanized monoclonal Ab that blocks the binding of EGF and TGFalpha ligands to the receptor
No Ab-dependent cellular toxicity rxn
Bevacizumab
Humanized monoclonal Ab primarily against VEGFa that inhibits its interaction with VEGF receptors -> inhibits angiogenesis in tumors and in normal tissues
Tx: colon cancer
R: shift to VEGFc or VEGFd; upreg of angiogenic factors
T: Severe HTN, hemorrhage, proteinuria, CHF, hemorrhage, gastric perforation; dose-related
Cisplatin
Produces crosslinks between adjacent guanines in DNA
Water replaces the Cl to activate the drug
T: myelosupp, N/V
Oxaliplatin
Intrastrand crosslinker
Contains platinum atom complexed with ocalate and DACH -> oxalate leaves and the bulky DACH is thought to contribute greater cytotoxicity than cisplatin
T: peripheral neuropathy
Mitomycin
Crosslinks DNA (alkylator) -> apoptosis
Tx: pancreatic, stomach, and colon cancer
T: myelosupp
Streptozocin
Methylnitrosurea + glucose -> glucose makes it bind to islets of Langerhans in pancreas -> specific for pancreatic cancer
Forms only the alkylating froup and not the carbamoylating group -> alkylates DNA (no carbamoylated proteins formed)
Causes lass myelosupp than other nitrosoureas (that produce carbamoylated proteins)
Paclitaxel
Binds to B-tubulin subunit of tubulin and blocks the disassembly of the microtubule bundles to prodice aberrant mictrotubule structures -> inhibits mitosis
Tx: carcinoma of the esophagus, ovary, breast, cervix, lung, and bladder
R: incr expression of p-glycoprotein POP and B-tubulin mutations
T: neutropenia and peripheral neuropathy
Gemcitabine
Inhibits DNA synthesis and is incorporated into DNA to induce apoptosis -> active against both rapidly dividing tumor cells and solid tumors
Tx: first choice agent for metastatic pancreatic cancer and esophageal cancer
T: myelosup; slowly progressive hemolytic uremic syndrome
C/I: radiation therapy
Vancomycin
Given IV; poorly absorbed orally
Binds to D-Ala-D-Ala precursor to inhibit transglycosylase
Teicoplanin
Given IV or IM; poorly absorbed orally
Inhibits peptidoglycan polymerization -> inhibits bacterial cell wall synthesis
Bacitracin
Used topically in dermatologic and ophthalmic ointments; not absorbed orallyInhibits bacterial cell wall synthesis by interfering with dephosphorylation of a lipid transport molecule which carries the building blocks of the peptidoglycan bacterial cell wall
T: nephrotoxicity if given parenterally